Diabetes, Obesity and Metabolism

Cover image for Vol. 16 Issue 5

Accepted Articles (Accepted, unedited articles published online and citable. The final edited and typeset version of record will appear in future.)

Edited By: R. Donnelly and A. Garber

Impact Factor: 5.181

ISI Journal Citation Reports © Ranking: 2012: 20/122 (Endocrinology & Metabolism)

Online ISSN: 1463-1326


  1. 1 - 11

    1. You have full text access to this OnlineOpen article
    2. Association between first-line monotherapy with sulfonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study

      C.Ll. Morgan, J. Mukherjee, S. Jenkins-Jones, S.E. Holden and C.J. Currie

      Accepted manuscript online: 11 APR 2014 03:10AM EST | DOI: 10.1111/dom.12302

    3. Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single centre, randomised controlled trial

      Tim Heise, Leszek Nosek, Sibylle Dellweg, Eric Zijlstra, Kezia Ann Præstmark, Jonas Kildegaard, Gert Nielsen and Thomas Sparre

      Accepted manuscript online: 11 APR 2014 03:08AM EST | DOI: 10.1111/dom.12304

    4. Effect of hyperglycaemia on muscarinic M3 receptor expression and secretory sensitivity to cholinergic receptor activation in islets.

      Astrid C. Hauge-Evans, Christina Reers, Alan Kerby, Zara Franklin, Stefan Amisten, Aileen J. King, Zoheb Hassan, Alonso Vilches-Flores, Zayd Tippu, Shanta J. Persaud and Peter M. Jones

      Accepted manuscript online: 11 APR 2014 03:08AM EST | DOI: 10.1111/dom.12301


    1. Evidence for inhibitory autocrine effects of proinsulin C-peptide on pancreatic beta cell function and insulin secretion

      A. M. McKillop, M. T. Ng, Y. H. A. Abdel-Wahab and P. R. Flatt

      Accepted manuscript online: 7 APR 2014 04:00AM EST | DOI: 10.1111/dom.12300


    1. Efficacy and safety of insulin degludec given as part of basal − bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomised, open-label, treat-to-target non-inferiority trial

      M.J. Davies, J.L. Gross, Y. Ono, T. Sasaki, G. Bantwal, M.A. Gall, M. Niemeyer and H. Seino, on behalf of the BEGIN BB T1 study group

      Accepted manuscript online: 7 APR 2014 03:33AM EST | DOI: 10.1111/dom.12298

    2. Interleukin-6 in combination with the interleukin-6 receptor stimulates glucose uptake in resting human skeletal muscle independently of insulin action

      A. Saini, S.H. Faulkner, H. Moir, P. Warwick, J. King and M.A. Nimmo

      Accepted manuscript online: 7 APR 2014 03:32AM EST | DOI: 10.1111/dom.12299


    1. A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs.

      Carlo B. Giorda, Elisa Nada, Barbara Tartaglino, Lisa Marafetti and Roberto Gnavi

      Accepted manuscript online: 4 APR 2014 08:55AM EST | DOI: 10.1111/dom.12297


    1. The Glucagon-like Peptide-1-Based Therapeutics Exenatide and Saxagliptin Did Not Cause Detrimental Effects on the Pancreas in Mice, Rats, Dogs, and Monkeys

      Denis Roy, Kristina D. Chadwick, Krystyna Tatarkiewicz, Carl LaCerte, Ann-Marie Bergholm, Thomas Brodie, Raja S. Mangipudy, David Parkes, Michael J. Graziano and Timothy P. Reilly

      Accepted manuscript online: 26 MAR 2014 02:56AM EST | DOI: 10.1111/dom.12294


    1. Review of Reviews 2014: a virtual issue

      Richard IG Holt

      Accepted manuscript online: 18 FEB 2014 06:29AM EST | DOI: 10.1111/dom.12279

  7. Letter

    1. Cardiovascular safety of sulfonylurea: comment on the study by Monami et al.

      Liang Du, Yuehong Chen, Jiani Shen, Yuanling Peng and Xin Sun

      Accepted manuscript online: 5 DEC 2013 11:11AM EST | DOI: 10.1111/dom.12245


  1. 1 - 11